GABAA Receptor Promoter Hypermethylation in Suicide Brain: Implications for the Involvement of Epigenetic Processes

Michael O. Poulter; Lisheng Du; Ian C.G. Weaver; Miklós Palkovits; Gábor Faludi; Zul Merali; Moshe Szyf; Hymie Anisman

doi:10.1016/j.biopsych.2008.05.028

GABA_A Receptor Promoter Hypermethylation in Suicide Brain: Implications for the Involvement of Epigenetic Processes

Michael O. Poulter, Lisheng Du, Ian C.G. Weaver, Miklós Palkovits, Gábor Faludi, Zul Merali, Moshe Szyf, Hymie Anisman

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	645-652
页数	8
期刊	Biological Psychiatry
卷	64
期	8
DOI	https://doi.org/10.1016/j.biopsych.2008.05.028
出版状态	已出版 - 10月 15 2008
已对外发布	是

!!!ASJC Scopus Subject Areas

生物精神病学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1016/j.biopsych.2008.05.028

其它文件与链接

引用此

@article{fa4f844445c04c039e0f223e689f8744,

title = "GABAA Receptor Promoter Hypermethylation in Suicide Brain: Implications for the Involvement of Epigenetic Processes",

author = "Poulter, {Michael O.} and Lisheng Du and Weaver, {Ian C.G.} and Mikl{\'o}s Palkovits and G{\'a}bor Faludi and Zul Merali and Moshe Szyf and Hymie Anisman",

note = "Funding Information: This research was supported by a Canadian Institutes of Health Research operating grant to MOP, HA, MS, and ZM and by European Union Grant No. FP6, BNEII No. LSHM-CT-2004-503039 to MP. A National Alliance for Research in Schizophrenia and Depression Independent Researcher Award also supports MOP. HA is a Tier I Canada Research Chair. We thank Jin Liu and Douglas Salgado for their technical assistance. ",

year = "2008",

month = oct,

day = "15",

doi = "10.1016/j.biopsych.2008.05.028",

language = "English",

volume = "64",

pages = "645--652",

journal = "Biological Psychiatry",

issn = "0006-3223",

publisher = "Elsevier USA",

number = "8",

}

TY - JOUR

T1 - GABAA Receptor Promoter Hypermethylation in Suicide Brain

T2 - Implications for the Involvement of Epigenetic Processes

AU - Poulter, Michael O.

AU - Du, Lisheng

AU - Weaver, Ian C.G.

AU - Palkovits, Miklós

AU - Faludi, Gábor

AU - Merali, Zul

AU - Szyf, Moshe

AU - Anisman, Hymie

N1 - Funding Information: This research was supported by a Canadian Institutes of Health Research operating grant to MOP, HA, MS, and ZM and by European Union Grant No. FP6, BNEII No. LSHM-CT-2004-503039 to MP. A National Alliance for Research in Schizophrenia and Depression Independent Researcher Award also supports MOP. HA is a Tier I Canada Research Chair. We thank Jin Liu and Douglas Salgado for their technical assistance.

PY - 2008/10/15

Y1 - 2008/10/15

UR - http://www.scopus.com/inward/record.url?scp=52949099506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949099506&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2008.05.028

DO - 10.1016/j.biopsych.2008.05.028

M3 - Article

C2 - 18639864

AN - SCOPUS:52949099506

SN - 0006-3223

VL - 64

SP - 645

EP - 652

JO - Biological Psychiatry

JF - Biological Psychiatry

IS - 8

ER -